Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Statins linked to fewer pneumonia hospitalizations in older adults, but more respiratory illness in primary care. A large UK cohort study found that older adults who started statins had a 14–17% lower risk of being hospitalized with pneumonia or acute respiratory infections — yet showed up more often with respiratory illness in primary care settings. Researchers say statins may reduce disease severity rather than prevent infection altogether.
Statins may shield older adults from severe respiratory infections — but the picture is complicated
A large UK population-based cohort study found that older adults (65+) who initiated statins had a 14% lower risk of being hospitalized with pneumonia and a 17% lower risk of hospitalization for acute respiratory infections compared to non-users. The study, published in Open Forum Infectious Diseases, analyzed data from nine annual cohorts (2010–2018) and matched over 35,000 statin initiators to nearly 178,000 non-users.
But here's the twist: in the primary care setting, statin users actually showed higher rates of influenza-like illness and acute respiratory infections — suggesting statins may reduce disease severity rather than prevent infection outright. Researchers hypothesize that statins may modulate the inflammatory response, helping prevent mild infections from progressing to serious illness requiring hospitalization.
By the Numbers
Why it matters: For clinicians managing older patients on statins, these findings add nuance — statins may offer a protective effect against severe respiratory illness, but residual confounding and differences in healthcare-seeking behavior mean the jury is still out on a definitive causal link.
